Terms: = Germ cell tumor AND IL2, IL-2, 3558, ENSG00000109471, P60568
1757 results:
1. Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics.
Phoon YP; Lopes JE; Pfannenstiel LW; Marcela Diaz-Montero C; Tian YF; Ernstoff MS; Funchain P; Ko JS; Winquist R; Losey HC; Melenhorst JJ; Gastman BR
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604813
[TBL] [Abstract] [Full Text] [Related]
2. Choosing T-cell sources determines CAR-T cell activity in neuroblastoma.
García-García L; G Sánchez E; Ivanova M; Pastora K; Alcántara-Sánchez C; García-Martínez J; Martín-Antonio B; Ramírez M; González-Murillo Á
Front Immunol; 2024; 15():1375833. PubMed ID: 38601159
[TBL] [Abstract] [Full Text] [Related]
3. Oncolytic herpes simplex virus expressing il-2 controls glioblastoma growth and improves survival.
Bommareddy PK; Wakimoto H; Martuza RL; Kaufman HL; Rabkin SD; Saha D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38599661
[TBL] [Abstract] [Full Text] [Related]
4. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?
Fishman J; Buchbinder EI
Cancer J; 2024 Mar-Apr 01; 30(2):120-125. PubMed ID: 38527266
[TBL] [Abstract] [Full Text] [Related]
5. Quercetin Limits tumor Immune Escape through PDK1/CD47 Axis in Melanoma.
Li X; He X; Lin B; Li L; Deng Q; Wang C; Zhang J; Chen Y; Zhao J; Li X; Li Y; Xi Q; Zhang R
Am J Chin Med; 2024; 52(2):541-563. PubMed ID: 38490807
[TBL] [Abstract] [Full Text] [Related]
6. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
7. Pimecrolimus protects neuron-like SH-SY5Y cells against anti-inflammatory and anti-oxidant effects of both microglial secretome and hydrogen peroxide.
Kocanci FG; Erol AYG; Yildiz F; Eciroglu H
Scand J Immunol; 2024 Jan; 99(1):e13328. PubMed ID: 38441277
[TBL] [Abstract] [Full Text] [Related]
8. Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
Betof Warner A; Hamid O; Komanduri K; Amaria R; Butler MO; Haanen J; Nikiforow S; Puzanov I; Sarnaik A; Bishop MR; Schoenfeld AJ
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38423748
[TBL] [Abstract] [Full Text] [Related]
9. Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
Zhang W; Wang S
Melanoma Res; 2024 Jun; 34(3):215-224. PubMed ID: 38364052
[TBL] [Abstract] [Full Text] [Related]
10. Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
Fadul CE; Thakur A; Kim J; Kassay-McAllister J; Schalk D; Lopes MB; Donahue J; Purow B; Dillon P; Le T; Schiff D; Liu Q; Lum LG
J Neurooncol; 2024 Jan; 166(2):321-330. PubMed ID: 38263486
[TBL] [Abstract] [Full Text] [Related]
11. Mouse Melanoma Model in tumor Vaccines and Immunotherapy Research.
De Robertis M; Lampreht Tratar U; Signori E; Komel T; Čemažar M
Methods Mol Biol; 2024; 2773():157-163. PubMed ID: 38236544
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
Toyofuku T; Ishikawa T; Nojima S; Kumanogoh A
J Immunol; 2024 Mar; 212(5):917-927. PubMed ID: 38214607
[TBL] [Abstract] [Full Text] [Related]
13. NK cells propagate T cell immunity following in situ tumor vaccination.
Jin WJ; Jagodinsky JC; Vera JM; Clark PA; Zuleger CL; Erbe AK; Ong IM; Le T; Tetreault K; Berg T; Rakhmilevich AL; Kim K; Newton MA; Albertini MR; Sondel PM; Morris ZS
Cell Rep; 2023 Dec; 42(12):113556. PubMed ID: 38096050
[TBL] [Abstract] [Full Text] [Related]
14. Celastrol, which targets il-2/CD25 binding inhibition, induces T cell-mediated antitumor activity in melanoma.
Cho O; Lee JW; Jeong YJ; Kim LK; Jung BK; Heo TH
Eur J Pharmacol; 2024 Jan; 962():176239. PubMed ID: 38043776
[TBL] [Abstract] [Full Text] [Related]
15. Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.
Kalaitsidou M; Moon OR; Sykorova M; Bao L; Qu Y; Sukumaran S; Valentine M; Zhou X; Pandey V; Foos K; Medvedev S; Powell DJ; Udyavar A; Gschweng E; Rodriguez R; Dudley ME; Hawkins RE; Kueberuwa G; Bridgeman JS
Front Immunol; 2023; 14():1256491. PubMed ID: 38022678
[TBL] [Abstract] [Full Text] [Related]
16. Incidence rate and histology of appendiceal neoplasms in complicated versus uncomplicated appendicitis: A meta-analysis and systematic review.
Solis-Pazmino P; Oka K; La K; Termeie O; Figueroa LA; Pilatuna E; Solis-Pazmino D; Harnegie MP; Cohen J; Barnajian M; Nasseri Y
Langenbecks Arch Surg; 2023 Nov; 408(1):432. PubMed ID: 37940770
[TBL] [Abstract] [Full Text] [Related]
17. Correlations between inflammatory cytokine levels and degree of pigmentation in acral melanomas.
Kim HE; Kim J; Park HK; Lee JB; Yun SJ
Melanoma Res; 2024 Feb; 34(1):38-43. PubMed ID: 37924528
[TBL] [Abstract] [Full Text] [Related]
18. In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4
Awad RM; De Vlaeminck Y; Meeus F; Ertveldt T; Zeven K; Ceuppens H; Goyvaerts C; Verdonck M; Salguero G; Raes G; Devoogdt N; Breckpot K
Sci Rep; 2023 Nov; 13(1):18995. PubMed ID: 37923822
[TBL] [Abstract] [Full Text] [Related]
19. Glioma-derived S100A9 polarizes M2 microglia to inhibit CD8+T lymphocytes for immunosuppression via αvβ3 integrin/AKT1/TGFβ1.
Huang N; Tang J; Yi X; Zhang M; Li B; Cheng Y; Chen J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119619. PubMed ID: 37907196
[TBL] [Abstract] [Full Text] [Related]
20. Cytokines impact natural killer cell phenotype and functionality against glioblastoma
Sivonen M; Sirviö KA; Wojciechowski S; Kailaanmäki A; Kaipainen S; Bailey A; Villalba M; Kekarainen T
Front Immunol; 2023; 14():1227064. PubMed ID: 37841273
[TBL] [Abstract] [Full Text] [Related]
[Next]
